文献速递冠心病心力衰竭与心肌病

急性冠脉综合征后生存与心力衰竭发展的性别差异

Is There a Sex Gap in Surviving an Acute Coronary Syndrome or Subsequent Development of Heart Failure?
PubMed 文献 · Circulation · 2020-11-30

基于2002至2016年45 064例首次心肌梗死患者的人群队列,女性年龄更大、合并症更多、冠脉造影率更低。女性STEMI院内死亡率调整后仍显著高于男性(aOR 1.42),出院后心力衰竭发生率也更高,且5年内死亡与心衰风险差异持续存在。

要点

  • 女性STEMI患者调整后院内死亡风险仍高于男性(aOR 1.42,95%CI 1.24-1.64)。
  • 女性出院后STEMI及NSTEMI后心力衰竭发生率均高于男性。
  • 女性冠脉造影率低于男性(74% vs 87%),但差异不能完全解释预后差距。

核心结论

  • 尽管临床结局的性别差异随时间有所减弱,女性在STEMI或NSTEMI后5年内死亡或发生心力衰竭的风险仍高于男性。

研究设计与样本

  • 基于人群的大型队列研究,纳入2002年4月1日至2016年3月31日期间45 064例首次心肌梗死住院患者,其中女性13 878例(30.8%)。

主要发现

  • 女性年龄更大(中位72岁 vs 61岁),合并症更多,诊断性冠脉造影率更低(74% vs 87%)。
  • 造影时女性左主干、近端前降支双支病变或三支病变比例低于男性(33.4% vs 40.9%,P<0.0001),单支病变或非阻塞性冠脉病比例更高(39.6% vs 29.1%,P<0.0001)。
  • 女性STEMI院内未调整死亡率高于男性(9.4% vs 4.5%),调整后仍显著(aOR 1.42,95%CI 1.24-1.64);NSTEMI调整后差异不显著(aOR 0.97,95%CI 0.83-1.13)。
  • 出院后女性STEMI后心衰发生率为22.5%(男性14.9%),NSTEMI后为23.2%(男性15.7%)。

临床怎么用

  • 对女性心肌梗死患者应关注其更高的死亡和心衰风险,尤其STEMI后,需加强随访和心衰监测。

局限性

  • 观察性研究,可能存在未测量混杂因素;原文未详细说明其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We hypothesized that disparities between sexes in the management of myocardial infarction (MI) may have changed over time, and thus altered the prognoses after MI, especially the risk for the development of heart failure. METHODS: Using a large population-based cohort of patients with MI between April 1, 2002, and March 31, 2016, we examined the incidence, angiographic findings, treatment (including revascularization), and clinical outcomes of patients with a first-time MI. To elucidate the differences between sexes, a series of multivariable models were created to explore all MI and non-ST-segment-elevation MI (NSTEMI) versus ST-segment-elevation MI (STEMI) over time. RESULTS: Between 2002 and 2016, 45 064 patients (13 878 [30.8%] women) were hospitalized with a primary diagnosis of first-time MI (54.9% NSTEMI and 45.1% STEMI). Women were older (median age, 72 versus 61 years), had more comorbidities, and had lower rates of diagnostic angiography than did men (women, 74%, versus men, 87%). When angiography was performed, women had a lower proportion of left main, 2-vessel disease with proximal left anterior descending or 3-vessel disease compared with men (33.4% versus 40.9%, P<0.0001), and a higher frequency of 1-vessel disease or nonobstructive coronary artery disease (39.6% versus 29.1%, P<0.0001). Women had a higher unadjusted rate of in-hospital mortality than did men in both patients with STEMI (women, 9.4%, versus men, 4.5%) and patients with NSTEMI (women, 4.7%, versus men, 2.9%). After adjustment, this difference remained significant in STEMI (adjusted odds ratio, 1.42 [95% CI, 1.24-1.64]) but not in NSTEMI (adjusted odds ratio, 0.97 [95% CI, 0.83-1.13]). After discharge, women developed heart failure after STEMI (women, 22.5%, versus men, 14.9%) as well as after NSTEMI (women, 23.2%, versus men, 15.7%). The adjusted relative risk for women versus men of developing the outcomes of mortality and heart failure remained similar across years, although the differences were nonsignificantly attenuated over 5 years of follow-up. CONCLUSIONS: Although some attenuation of differences in clinical outcomes over time has occurred, women remain at higher risk than men of dying or developing heart failure in the subsequent 5 years after STEMI or NSTEMI, even after accounting for differences in angiographic findings, revascularization, and other confounders.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Ezekowitz JA, Savu A, Welsh RC, et al. Is There a Sex Gap in Surviving an Acute Coronary Syndrome or Subsequent Development of Heart Failure? Circulation. 2020. PMID: 33249922. doi:10.1161/CIRCULATIONAHA.120.048015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。